Galectin Therapeutics Inc — Cash Flow (NASDAQ:GALT) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 20.6 M24.31 M31.06 M32.97 M41.8 M 30.6 M Cash from investing activities 00000 — Cash from financing activities 263 K36.81 M10 M40.03 M31.23 M 15.09 M Free cash flow 20.6 M24.31 M31.06 M32.97 M41.8 M 30.6 M

Notizie

Il direttore di Galectin Therapeutics Marc Rubin si dimette dal consiglio

Galectin Therapeutics director Marc Rubin resigns from board

Il CFO di Galectin Therapeutics vende azioni per 233.000 dollari

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Il titolo Galectin Therapeutics crolla dopo il feedback della FDA sul farmaco

Galectin Therapeutics stock plummets after FDA feedback on drug

La FDA fornisce feedback sul programma di sviluppo di belapectin di Galectin

FDA provides feedback on Galectin’s belapectin development program

Direttore di Galectin Therapeutics vende azioni per 1,05 milioni di dollari

Gli azionisti di Galectin Therapeutics eleggono membri del consiglio e approvano proposte chiave